(Q37333639)

19 August 2017

title

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? (English)

1 reference

19 August 2017

main subject

angiogenesis inhibitor

1 reference

Peter Carmeliet

1 reference

19 August 2017

Christian Fischer

1 reference

19 August 2017

Massimiliano Mazzone

series ordinal

1 reference

19 August 2017

Bart Jonckx

series ordinal

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

19 August 2017

published in

Nature Reviews Cancer

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

942-956

1 reference

VEGF-targeted therapy: mechanisms of anti-tumour activity.

19 August 2017

cites work

1 reference

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

31 March 2020

1 reference

New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways

31 March 2020

1 reference

Modes of resistance to anti-angiogenic therapy

31 March 2020

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

31 March 2020

1 reference

Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition

31 March 2020

1 reference

Angiogenesis in life, disease and medicine

31 March 2020

1 reference

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

31 March 2020

1 reference

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

31 March 2020

1 reference

Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia

31 March 2020

1 reference

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

31 March 2020

1 reference

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

31 March 2020

1 reference

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

31 March 2020

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

31 March 2020

1 reference

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

31 March 2020

1 reference

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

31 March 2020

1 reference

Autocrine VEGF signaling is required for vascular homeostasis

31 March 2020

1 reference

VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade

31 March 2020

1 reference

VEGF inhibition and renal thrombotic microangiopathy

31 March 2020

1 reference

Vascular endothelial growth factor receptor family genes: when did the three genes phylogenetically segregate?

31 March 2020

1 reference

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

31 March 2020

1 reference

Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans

31 March 2020

1 reference

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

31 March 2020

1 reference

The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis

31 March 2020

1 reference

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

31 March 2020

1 reference

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

31 March 2020

1 reference

MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis

31 March 2020

1 reference

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase.

31 March 2020

1 reference

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages

31 March 2020

1 reference

Flt-1 signaling in macrophages promotes glioma growth in vivo.

31 March 2020

1 reference

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

31 March 2020

1 reference

Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

31 March 2020

1 reference

Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials

31 March 2020

1 reference

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

31 March 2020

1 reference

Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts

31 March 2020

1 reference

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

31 March 2020

1 reference

Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia

31 March 2020

1 reference

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

31 March 2020

1 reference

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

31 March 2020

1 reference

Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma.

31 March 2020

1 reference

Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms

31 March 2020

1 reference

Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa

31 March 2020

1 reference

Immunohistochemical study about the Flt-1/VEGFR1 expression in the gastrointestinal tract of mouse, rat, dog, swine and monkey

31 March 2020

1 reference

Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia

31 March 2020

1 reference

Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer

31 March 2020

1 reference

The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma

31 March 2020

1 reference

VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease.

31 March 2020

1 reference

Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia

31 March 2020

1 reference

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

31 March 2020

1 reference

The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching.

31 March 2020

1 reference

Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer

31 March 2020

1 reference

Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes

31 March 2020

1 reference

Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer

31 March 2020

1 reference

Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis

31 March 2020

1 reference

Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer

31 March 2020

1 reference

VEGF-Trap: a VEGF blocker with potent antitumor effects

31 March 2020

1 reference

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

31 March 2020

1 reference

Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys

31 March 2020

1 reference

Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis

31 March 2020

1 reference

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

31 March 2020

1 reference

A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library

31 March 2020

1 reference

Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide.

31 March 2020

1 reference

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

31 March 2020

1 reference

Simultaneous blockade of VEGFR-1 and VEGFR-2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation

31 March 2020

1 reference

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

31 March 2020

1 reference

The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.

31 March 2020

1 reference

The biology of vascular endothelial growth factor-B (VEGF-B).

31 March 2020

1 reference

Isoform-specific expression of VEGF-B in normal tissues and tumors

31 March 2020

1 reference

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

31 March 2020

1 reference

Vascular endothelial growth factor-B promotes in vivo angiogenesis

31 March 2020

1 reference

Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation

31 March 2020

1 reference

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium

31 March 2020

1 reference

Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect

31 March 2020

1 reference

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

31 March 2020

1 reference

Expression and localization of placenta growth factor and PlGF receptors in human meningiomas

31 March 2020

1 reference

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression

31 March 2020

1 reference

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.

31 March 2020

1 reference

Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma

31 March 2020

1 reference

Prophylactic but not therapeutic activity of a monoclonal antibody that neutralizes the binding of VEGF-B to VEGFR-1 in a murine collagen-induced arthritis model

31 March 2020

1 reference

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

31 March 2020

1 reference

Neuropilin-1 is a placenta growth factor-2 receptor

31 March 2020

1 reference

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

31 March 2020

1 reference

Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis

31 March 2020

1 reference

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment

31 March 2020

1 reference

VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism

31 March 2020

1 reference

Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) -/- mice

31 March 2020

1 reference

Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment

31 March 2020

1 reference

Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor

31 March 2020

1 reference

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

31 March 2020

1 reference

Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A

31 March 2020

1 reference

Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF.

31 March 2020

1 reference

The placenta growth factor in skin angiogenesis

31 March 2020

1 reference

Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion

31 March 2020

1 reference

Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance

31 March 2020

1 reference

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential

31 March 2020

1 reference

PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle

31 March 2020

1 reference

Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation

31 March 2020

1 reference

A critical role of placental growth factor in the induction of inflammation and edema formation

31 March 2020

1 reference

VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.

31 March 2020

1 reference

Placenta growth factor is induced in human keratinocytes during wound healing

31 March 2020

1 reference

VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells.

31 March 2020

1 reference

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

31 March 2020

1 reference

Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells

31 March 2020

1 reference

VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization

31 March 2020

1 reference

Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models

31 March 2020

1 reference

Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis

31 March 2020

1 reference

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers

31 March 2020

1 reference

Blockage of VEGF-induced angiogenesis by preventing VEGF secretion

31 March 2020

1 reference

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

31 March 2020

1 reference

Placenta growth factor is not required for exercise-induced angiogenesis.

31 March 2020

1 reference

Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.

31 March 2020

1 reference

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

31 March 2020

1 reference

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

31 March 2020

1 reference

Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells.

31 March 2020

1 reference

The discovery of the placental growth factor and its role in angiogenesis: a historical review

31 March 2020

1 reference

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

31 March 2020

1 reference

Genetic deletion of placenta growth factor in mice alters uterine NK cells

31 March 2020

1 reference

Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia

31 March 2020

1 reference

Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair

31 March 2020

1 reference

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

31 March 2020

1 reference

Impaired adipose tissue development in mice with inactivation of placental growth factor function

31 March 2020

1 reference

Loss of placental growth factor protects mice against vascular permeability in pathological conditions

31 March 2020

1 reference

Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy

31 March 2020

1 reference

Human retinal epithelium produces and responds to placenta growth factor

31 March 2020

1 reference

Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release

31 March 2020

1 reference

Placenta growth factor expression is correlated with survival of patients with colorectal cancer

31 March 2020

1 reference

Placenta growth factor is over-expressed and has prognostic value in human breast cancer

31 March 2020

1 reference

The inflammatory side of human chondrocytes unveiled by antibody microarrays

31 March 2020

1 reference

Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.

31 March 2020

1 reference

Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.

31 March 2020

1 reference

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

31 March 2020

1 reference

The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.

31 March 2020

1 reference

Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance

31 March 2020

1 reference

Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence

31 March 2020

1 reference

Placenta growth factor (PlGF) mRNA expression in brain tumors

31 March 2020

1 reference

Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma

31 March 2020

1 reference

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

31 March 2020

1 reference

Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.

31 March 2020

1 reference

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

31 March 2020

1 reference

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

31 March 2020

1 reference

Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence

31 March 2020

1 reference

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

31 March 2020

1 reference

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

31 March 2020

1 reference

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

31 March 2020

1 reference

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

31 March 2020

1 reference

VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment

31 March 2020

1 reference

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

31 March 2020

1 reference

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

31 March 2020

1 reference

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

31 March 2020

1 reference

VEGFR1 for lymphangiogenesis: an alternative signaling pathway?

31 March 2020

1 reference

Tumour-educated macrophages promote tumour progression and metastasis

31 March 2020

1 reference

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

31 March 2020

1 reference

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

31 March 2020

1 reference

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

31 March 2020

1 reference

Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis

31 March 2020

1 reference

Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

31 March 2020

1 reference

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

31 March 2020

1 reference

Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury

31 March 2020

1 reference

Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration

31 March 2020

1 reference

Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice

31 March 2020

1 reference

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

31 March 2020

1 reference

Vascular Effects of FGF-2 and VEGF-B in Rabbits with Bilateral Hind Limb Ischemia

31 March 2020

1 reference

Vascular endothelial growth factor-B and retinal vascular development in the mouse

31 March 2020

1 reference

Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension

31 March 2020

1 reference

Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension

31 March 2020

1 reference

Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue

31 March 2020

1 reference

Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipop

31 March 2020

1 reference

VEGF family members regulate myocardial tubulogenesis and coronary artery formation in the embryo

31 March 2020

1 reference

Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro

31 March 2020

1 reference

Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis

31 March 2020

1 reference

Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy

31 March 2020

1 reference

Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity

31 March 2020

1 reference

Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.

31 March 2020

1 reference

Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates

31 March 2020

1 reference

VEGF signaling on hematopoietic precursors restricts B-lymphoid commitment in vitro and in vivo

31 March 2020

1 reference

Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density

31 March 2020

1 reference

Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia

31 March 2020

1 reference

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

31 March 2020

1 reference

Selective Downregulation of VEGF-A 165 , VEGF-R 1 , and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy

31 March 2020

1 reference

Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC2524

1 reference

19 August 2017

1 reference